Alignment Healthcare Future Growth
Future criteria checks 2/6
Alignment Healthcare is forecast to grow earnings and revenue by 38.3% and 20.6% per annum respectively. EPS is expected to grow by 40% per annum. Return on equity is forecast to be -78.6% in 3 years.
Key information
38.3%
Earnings growth rate
40.0%
EPS growth rate
| Healthcare earnings growth | 17.3% |
| Revenue growth rate | 20.6% |
| Future return on equity | -78.6% |
| Analyst coverage | Good |
| Last updated | 16 Jan 2025 |
Recent future growth updates
Recent updates
Further Upside For Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares Could Introduce Price Risks After 34% Bounce
Jan 17
Alignment Healthcare: Growth For Growth's Sake
Jan 15A Piece Of The Puzzle Missing From Alignment Healthcare, Inc.'s (NASDAQ:ALHC) 30% Share Price Climb
Nov 07Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Intrinsic Value Is Potentially 73% Above Its Share Price
Oct 14Even With A 30% Surge, Cautious Investors Are Not Rewarding Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Performance Completely
Sep 12Alignment Healthcare (NASDAQ:ALHC) Has Debt But No Earnings; Should You Worry?
Sep 10Earnings Update: Here's Why Analysts Just Lifted Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$9.55
Aug 04Market Might Still Lack Some Conviction On Alignment Healthcare, Inc. (NASDAQ:ALHC) Even After 27% Share Price Boost
Jul 18Is Now An Opportune Moment To Examine Alignment Healthcare, Inc. (NASDAQ:ALHC)?
Jul 12An Intrinsic Calculation For Alignment Healthcare, Inc. (NASDAQ:ALHC) Suggests It's 26% Undervalued
Jun 20The Market Lifts Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares 37% But It Can Do More
May 30Is Alignment Healthcare (NASDAQ:ALHC) Weighed On By Its Debt Load?
Apr 19It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)
Feb 24Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?
Jan 18Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity
Nov 08Alignment Healthcare: Investors Should Align Themselves With Insiders
Oct 05Alignment Healthcare announces 9M shares secondary offering
Sep 15Alignment Healthcare completes debt refinancing
Sep 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 5,170 | -35 | N/A | N/A | 3 |
| 12/31/2026 | 4,288 | -80 | 60 | 95 | 10 |
| 12/31/2025 | 3,478 | -95 | 31 | 77 | 11 |
| 12/31/2024 | 2,677 | -131 | -18 | -8 | 11 |
| 9/30/2024 | 2,468 | -144 | -187 | -144 | N/A |
| 6/30/2024 | 2,232 | -153 | -207 | -164 | N/A |
| 3/31/2024 | 2,013 | -157 | -190 | -151 | N/A |
| 12/31/2023 | 1,824 | -148 | -95 | -59 | N/A |
| 9/30/2023 | 1,720 | -158 | -53 | -21 | N/A |
| 6/30/2023 | 1,624 | -163 | 49 | 78 | N/A |
| 3/31/2023 | 1,528 | -146 | 25 | 51 | N/A |
| 12/31/2022 | 1,434 | -150 | -69 | -45 | N/A |
| 9/30/2022 | 1,371 | -140 | 53 | 74 | N/A |
| 6/30/2022 | 1,304 | -146 | -38 | -19 | N/A |
| 3/31/2022 | 1,246 | -179 | -73 | -52 | N/A |
| 12/31/2021 | 1,168 | -195 | -99 | -79 | N/A |
| 9/30/2021 | 1,112 | -180 | -80 | -59 | N/A |
| 6/30/2021 | 1,066 | -123 | -66 | -46 | N/A |
| 3/31/2021 | 1,002 | -70 | -26 | -9 | N/A |
| 12/31/2020 | 959 | -23 | -8 | 8 | N/A |
| 12/31/2019 | 757 | -45 | -1 | 9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALHC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ALHC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ALHC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ALHC's revenue (20.6% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: ALHC's revenue (20.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALHC is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 13:53 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alignment Healthcare, Inc. is covered by 18 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hua Ha | Baird |
| Sarah James | Barclays |
| Andrew Mok | Barclays |